MAPK8 and colorectal carcinoma: 3.6. GSK2606414 (GSK), a PERK Inhibitor, Inhibited TAX- and NOC-Induced Cell Death and G2/M Arrest with Suppression of PERK and JNK Protein Phosphorylation in Human CRC Cells